for people ages 18 years and up (full criteria)
at San Francisco, California
study started
estimated completion
Andreea L. Seritan, MD



This study aims to explore the feasibility and effectiveness of mindfulness-based cognitive therapy (MBCT) in reducing anxiety and/or depressive symptoms in people with Parkinson's disease.

Official Title

Mindfulness-based Cognitive Therapy for People With Parkinson's Disease


An adapted MBCT intervention will be offered to people with Parkinson's disease and mild-to-moderate depression and/or anxiety. Two 8-week long MBCT groups will be held between September 2019 and March 2020, based on the adapted protocol. Modifications will include shortening the traditional 120-minute to 60-minute format and performing mindful yoga from a chair, instead of a floor mat. Participants will be recruited from the community, according to the eligibility criteria detailed below. The participants' pre- and post-MBCT anxiety and/or depressive symptom severity and mindfulness levels (as measured with standardized, validated scales) will be compared, using a paired t-test.


Parkinson Disease Anxiety Depression Parkinson's disease Mindfulness-based intervention Mindfulness-based cognitive therapy (MBCT)


You can join if…

Open to people ages 18 years and up

  1. Diagnosis of Parkinson's disease (established by a neurologist)
  2. Living in the San Francisco Bay Area
  3. Being able and willing to attend 8 weekly 60-minute group sessions
  4. Mild-to-moderate anxiety: GAD-7 score ≤ 14
  5. Mild-to-moderate depression: PHQ-9 score ≤ 14

You CAN'T join if...

  1. Severe anxiety: GAD-7 score > 15
  2. Moderately severe-to-severe depression: PHQ-9 score > 15
  3. Cognitive impairment: Montreal Cognitive Assessment (MoCA) score < 24
  4. Heavy alcohol or drug use
  5. Severe psychosis
  6. Active suicidal or homicidal ideation
  7. Severe motor fluctuations (less than 2 hours "on" time per day)


  • University of California, San Francisco accepting new patients
    San Francisco California 94143 United States

Lead Scientist

  • Andreea L. Seritan, MD
    Dr. Seritan is a geriatric psychiatrist and a psychodynamic therapist. In her clinical practice, she combines psychopharmacological management with psychotherapy for each patient. Before joining UCSF, Dr. Seritan was with the Department of Psychiatry and Behavioral Sciences at the University of California, Davis, where she also served as associate dean for student wellness.


accepting new patients
Start Date
Completion Date
University of California, San Francisco
Study Type
Last Updated